No Prescription |
 |
 | ||
|
Lorfast Meltabs Claritin |
|
| ||
No Prescription » Prescription Drugs 10 » Lorfast Meltabs Claritin Loratadine is used to temporarily relieve the symptoms of hay fever (allergy to pollen dust or other substances in the air) and other allergies. These symptoms include sneezing runny nose and itchy eyes nose or throat. Loratadine is also used to treat itching and redness caused by hives. However loratadine does not prevent hives or other allergic skin reactions. Loratadine is in a class of medications called antihistamines. It works by blocking the action of histamine a substance in the body that causes allergic symptoms. Buy Lorfast Meltabs Claritin and other Prescription Drugs 10 products online at Medstore. Buy Online at Medstore - Click Here!
About Lorfast Meltabs Claritin: Product Type: Prescription Drugs 10 Lorfast Meltabs (Claritin Dimetapp Agistam Generic Loratadine) Lorfast Meltabs (Claritin Dimetapp Agistam Generic Loratadine) Claritin Dimetapp Agistam Generic Loratadine 10mg Claritin Dimetapp Agistam Generic Loratadine Lorfast Meltabs
View more Prescription Drugs 10 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
